Gerodorm
Gerodorm - General Information
Gerodorm is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Gerodorm is not approved for sale in the United States or Canada.
Pharmacology of Gerodorm
Gerodorm is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Gerodorm is not approved for sale in the United States or Canada.
Additional information about Gerodorm
Gerodorm Indication: For the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms.
Mechanism Of Action: Gerodorm binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.
Drug Interactions: Not Available
Food Interactions: Avoid alcohol.
Take with food.
Avoid excessive quantities of coffee or tea (Caffeine).
Generic Name: Cinolazepam
Synonyms: Cinolazepamum [inn-latin]
Drug Category: Anticonvulsants; Sedatives and Hypnotics; Benzodiazepines
Drug Type: Small Molecule; Approved
Other Brand Names containing Cinolazepam: Gerodorm;
Absorption: Bioavailability following oral administration is 90-100%.
Toxicity (Overdose): The onset of impairment of consciousness is relatively rapid in benzodiazepine poisoning. Onset is more rapid following larger doses and with agents of shorter duration of action. The most common and initial symptom is somnolence. This may progress to coma Grade I or Grade II following very large ingestions.
Protein Binding: Not Available
Biotransformation: Hepatic.
Half Life: 9 hours
Dosage Forms of Gerodorm: Not Available
Chemical IUPAC Name: 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile
Chemical Formula: C18H13ClFN3O2
Cinolazepam on Wikipedia: https://en.wikipedia.org/wiki/Cinolazepam
Organisms Affected: Humans and other mammals